Pharmacology

Action Mechanism of Action Reference
BINDING AGENT Lymphocyte antigen 6E binding agent PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Neoplasms 1 D009369 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4297935
FDA SRS ONS92I2A7F